|
|
||||||||
Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of Munster, Munster, Germany
Bone marrow-derived dendritic cells (BmDC) are potent APC and can
promote antitumor immunity in mice when pulsed with tumor Ag. This
study aimed to define the culture conditions and maturation stages of
BmDC that enable them to optimally function as APC in vivo. BmDC
cultured under various conditions (granulocyte-macrophage CSF (GM-CSF)
or GM-CSF plus IL-4 alone or in combination with Flt3 ligand, TNF-
,
LPS, or CD40 ligand (CD40L)) were analyzed morphologically,
phenotypically, and functionally and were tested for their ability to
promote prophylactic and/or therapeutic antitumor immunity. Each of the
culture conditions generated typical BmDC. Whereas cells cultured in
GM-CSF alone were functionally immature, cells incubated with CD40L or
LPS were mature BmDC, as evident by morphology, capacity to internalize
Ag, migration into regional lymph nodes, IL-12 secretion, and
alloantigen or peptide Ag presentation in vitro. The remaining cultures
exhibited intermediate dendritic cell maturation. The in vivo
Ag-presenting capacity of BmDC was compared with respect to induction
of both protective tumor immunity and immunotherapy of established
tumors, using the poorly immunogenic squamous cell carcinoma, KLN205.
In correspondence to their maturation stage, BmDC cultured in the
presence of CD40L exhibited the most potent immunostimulatory effects.
In general, although not entirely, the capacity of BmDC to induce an
antitumor immune response in vivo correlated to their degree of
maturation. The present data support the clinical use of mature, rather
than immature, tumor Ag-pulsed dendritic cells as cancer vaccines and
identifies CD40L as a potent stimulus to enhance their in vivo
Ag-presenting capacity.
This article has been cited by other articles:
![]() |
F. Zhao, C. Falk, W. Osen, M. Kato, D. Schadendorf, and V. Umansky Activation of p38 Mitogen-Activated Protein Kinase Drives Dendritic Cells to Become Tolerogenic in Ret Transgenic Mice Spontaneously Developing Melanoma Clin. Cancer Res., July 1, 2009; 15(13): 4382 - 4390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mariotti, J. Foley, K. Ryan, N. Buxhoeveden, V. Kapoor, S. Amarnath, and D. H. Fowler Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway Blood, December 1, 2008; 112(12): 4765 - 4775. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Egeblad, A. J. Ewald, H. A. Askautrud, M. L. Truitt, B. E. Welm, E. Bainbridge, G. Peeters, M. F. Krummel, and Z. Werb Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy Dis. Model. Mech., September 1, 2008; 1(2-3): 155 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Y. Gerner, K. A. Casey, and M. F. Mescher Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses J. Immunol., July 1, 2008; 181(1): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Kim, S.-Y. Hwang, J.-S. Hwang, J.-W. Lee, E.-S. Oh, and I.-O. Han C6 Glioma Cell Insoluble Matrix Components Enhance Interferon-{gamma}-stimulated Inducible Nitric-oxide Synthase/Nitric Oxide Production in BV2 Microglial Cells J. Biol. Chem., February 1, 2008; 283(5): 2526 - 2533. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Fainaru, A. Adini, O. Benny, I. Adini, S. Short, L. Bazinet, K. Nakai, E. Pravda, M. D. Hornstein, R. J. D'Amato, et al. Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis FASEB J, February 1, 2008; 22(2): 522 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci IL-4 Suppresses Dendritic Cell Response to Type I Interferons J. Immunol., November 15, 2007; 179(10): 6446 - 6455. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Reichardt, B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser, and M. Gunzer Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse Blood, September 1, 2007; 110(5): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Phadke, G. Akangire, S. J. Park, S. A. Lira, and B. Mehrad The Role of CC Chemokine Receptor 6 in Host Defense in a Model of Invasive Pulmonary Aspergillosis Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Varga, S. Balkow, M. K. Wild, A. Stadtbaeumer, M. Krummen, T. Rothoeft, T. Higuchi, S. Beissert, K. Wethmar, K. Scharffetter-Kochanek, et al. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation Blood, January 15, 2007; 109(2): 661 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Udagawa, C. Kudo-Saito, G. Hasegawa, K. Yano, A. Yamamoto, M. Yaguchi, M. Toda, I. Azuma, T. Iwai, and Y. Kawakami Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation Clin. Cancer Res., December 15, 2006; 12(24): 7465 - 7475. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-G. de Goer de Herve, D. Durali, T.-A. Tran, G. Maigne, F. Simonetta, P. Leclerc, J.-F. Delfraissy, and Y. Taoufik Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40 Blood, October 15, 2005; 106(8): 2806 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Kang, H.-Y. Lee, M.-K. Kim, K. S. Park, Y. M. Park, J.-Y. Kwak, and Y.-S. Bae The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 2 J. Immunol., July 15, 2005; 175(2): 685 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yamanaka, J. Homma, N. Yajima, N. Tsuchiya, M. Sano, T. Kobayashi, S. Yoshida, T. Abe, M. Narita, M. Takahashi, et al. Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial Clin. Cancer Res., June 1, 2005; 11(11): 4160 - 4167. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Menges, T. Baumeister, S. Rossner, P. Stoitzner, N. Romani, A. Gessner, and M. B. Lutz IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity J. Leukoc. Biol., April 1, 2005; 77(4): 535 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, C. Nishiyama, M. Nishiyama, H. Matsuda, K. Maeda, Y. Akizawa, R. Tsuboi, K. Okumura, and H. Ogawa Mast Cells Acquire Monocyte-Specific Gene Expression and Monocyte-Like Morphology by Overproduction of PU.1 J. Immunol., January 1, 2005; 174(1): 376 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. D. van Mierlo, Z. F. H. M. Boonman, H. M. H. Dumortier, A. Th. den Boer, M. F. Fransen, J. Nouta, E. I. H. van der Voort, R. Offringa, R. E. M. Toes, and C. J. M. Melief Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication J. Immunol., December 1, 2004; 173(11): 6753 - 6759. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation J. Immunol., November 15, 2004; 173(10): 5923 - 5928. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gunzer, C. Weishaupt, A. Hillmer, Y. Basoglu, P. Friedl, K. E. Dittmar, W. Kolanus, G. Varga, and S. Grabbe A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo Blood, November 1, 2004; 104(9): 2801 - 2809. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katakai, T. Hara, M. Sugai, H. Gonda, and A. Shimizu Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes J. Exp. Med., September 20, 2004; 200(6): 783 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katakai, T. Hara, J.-H. Lee, H. Gonda, M. Sugai, and A. Shimizu A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells Int. Immunol., August 1, 2004; 16(8): 1133 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Fujii, K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation J. Exp. Med., June 21, 2004; 199(12): 1607 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Cisco, Z. Abdel-Wahab, J. Dannull, S. Nair, D. S. Tyler, E. Gilboa, J. Vieweg, Y. Daaka, and S. K. Pruitt Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4 J. Immunol., June 1, 2004; 172(11): 7162 - 7168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Terme, E. Tomasello, K. Maruyama, F. Crepineau, N. Chaput, C. Flament, J.-P. Marolleau, E. Angevin, E. F. Wagner, B. Salomon, et al. IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules J. Immunol., May 15, 2004; 172(10): 5957 - 5966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ramirez-Pineda, A. Frohlich, C. Berberich, and H. Moll Dendritic Cells (DC) Activated by CpG DNA Ex Vivo Are Potent Inducers of Host Resistance to an Intracellular Pathogen That Is Independent of IL-12 Derived from the Immunizing DC J. Immunol., May 15, 2004; 172(10): 6281 - 6289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nair, C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation J. Immunol., December 1, 2003; 171(11): 6275 - 6282. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xu, G. K. Koski, M. Faries, I. Bedrosian, R. Mick, M. Maeurer, M. A. Cheever, P. A. Cohen, and B. J. Czerniecki Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism J. Immunol., September 1, 2003; 171(5): 2251 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Doxsee, T. R. Riter, M. J. Reiter, S. J. Gibson, J. P. Vasilakos, and R. M. Kedl The Immune Response Modifier and Toll-Like Receptor 7 Agonist S-27609 Selectively Induces IL-12 and TNF-{alpha} Production in CD11c+CD11b+CD8- Dendritic Cells J. Immunol., August 1, 2003; 171(3): 1156 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, C. Roucard, C. Bocaccio, J.-P. Abastado, D. Charron, and N. Mooney Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells J. Leukoc. Biol., July 1, 2003; 74(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Camporeale, A. Boni, G. Iezzi, E. Degl'Innocenti, M. Grioni, A. Mondino, and M. Bellone Critical Impact of the Kinetics of Dendritic Cells Activation on the in Vivo Induction of Tumor-specific T Lymphocytes Cancer Res., July 1, 2003; 63(13): 3688 - 3694. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ghosh, C. Pal, M. Ray, S. Maitra, L. Mandal, and S. Bandyopadhyay Dendritic Cell-Based Immunotherapy Combined with Antimony-Based Chemotherapy Cures Established Murine Visceral Leishmaniasis J. Immunol., June 1, 2003; 170(11): 5625 - 5629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Flynn and B. Stockinger Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation Blood, June 1, 2003; 101(11): 4472 - 4478. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Yang and E. C. Lattime Tumor-induced Interleukin 10 Suppresses the Ability of Splenic Dendritic Cells to Stimulate CD4 and CD8 T-Cell Responses Cancer Res., May 1, 2003; 63(9): 2150 - 2157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Kobie, R. S. Wu, R. A. Kurt, S. Lou, M. K. Adelman, L. J. Whitesell, L. V. Ramanathapuram, C. L. Arteaga, and E. T. Akporiaye Transforming Growth Factor {beta} Inhibits the Antigen-Presenting Functions and Antitumor Activity of Dendritic Cell Vaccines Cancer Res., April 15, 2003; 63(8): 1860 - 1864. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Jiang, E. Muckersie, M. Robertson, and J. V. Forrester Antigen-Specific Inhibition of Experimental Autoimmune Uveoretinitis by Bone Marrow-Derived Immature Dendritic Cells Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1598 - 1607. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Soruri, Z. Kiafard, C. Dettmer, J. Riggert, J. Kohl, and J. Zwirner IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo J. Immunol., March 15, 2003; 170(6): 3306 - 3314. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Vorderstrasse, E. A. Dearstyne, and N. I. Kerkvliet Influence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Antigen-Presenting Activity of Dendritic Cells Toxicol. Sci., March 1, 2003; 72(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Hou, Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong, and B. Sun Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells J. Immunol., February 15, 2003; 170(4): 1728 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abe, F. O. Yarovinsky, T. Murakami, A. N. Shakhov, A. V. Tumanov, D. Ito, L. N. Drutskaya, K. Pfeffer, D. V. Kuprash, K. L. Komschlies, et al. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo Blood, February 15, 2003; 101(4): 1477 - 1483. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Weigel, N. Nath, P. A. Taylor, A. Panoskaltsis-Mortari, W. Chen, A. M. Krieg, K. Brasel, and B. R. Blazar Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses Blood, December 1, 2002; 100(12): 4169 - 4176. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Balmelli, S. Demotz, H. Acha-Orbea, P. De Grandi, and D. Nardelli-Haefliger Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles J. Virol., November 13, 2002; 76(24): 12596 - 12602. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-R. Jiang, E. Muckersie, M. Robertson, H. Xu, J. Liversidge, and J. V. Forrester Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture J. Leukoc. Biol., November 1, 2002; 72(5): 978 - 985. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al. Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors J. Immunol., November 1, 2002; 169(9): 5322 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lee, A. Mahtabifard, R. Yamada, R. G. Crystal, and R. J. Korst Adenovirus Vector-mediated Overexpression of a Truncated Form of the p65 Nuclear Factor {kappa}B cDNA in Dendritic Cells Enhances Their Function Resulting in Immune-mediated Suppression of Preexisting Murine Tumors Clin. Cancer Res., November 1, 2002; 8(11): 3561 - 3569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Arron, Y. Pewzner-Jung, M. C. Walsh, T. Kobayashi, and Y. Choi Regulation of the Subcellular Localization of Tumor Necrosis Factor Receptor-associated Factor (TRAF)2 by TRAF1 Reveals Mechanisms of TRAF2 Signaling J. Exp. Med., October 7, 2002; 196(7): 923 - 934. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Lutz, M. Schnare, M. Menges, S. Rossner, M. Rollinghoff, G. Schuler, and A. Gessner Differential Functions of IL-4 Receptor Types I and II for Dendritic Cell Maturation and IL-12 Production and Their Dependency on GM-CSF J. Immunol., October 1, 2002; 169(7): 3574 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Overexpression In Vivo Results in the Long-Term Recruitment of a Distinct Dendritic Cell Population with Enhanced Immunostimulatory Function J. Immunol., September 15, 2002; 169(6): 2875 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. O'Sullivan and R. Thomas CD40 Ligation Conditions Dendritic Cell Antigen-Presenting Function Through Sustained Activation of NF-{kappa}B J. Immunol., June 1, 2002; 168(11): 5491 - 5498. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Steptoe, J. M. Ritchie, and L. C. Harrison Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice J. Immunol., May 15, 2002; 168(10): 5032 - 5041. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Basak, A. Harui, M. Stolina, S. Sharma, K. Mitani, S. M. Dubinett, and M. D. Roth Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4 Blood, April 15, 2002; 99(8): 2869 - 2879. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bachleitner-Hofmann, A. Stift, J. Friedl, R. Pfragner, K. Radelbauer, P. Dubsky, G. Schuller, T. Benko, B. Niederle, C. Brostjan, et al. Stimulation of Autologous Antitumor T-Cell Responses Against Medullary Thyroid Carcinoma Using Tumor Lysate-Pulsed Dendritic Cells J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1098 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Q. Khan, Y. Shen, Z.-Q. Wu, T. A. Wynn, and C. M. Snapper Endogenous Pro- and Anti-Inflammatory Cytokines Differentially Regulate an In Vivo Humoral Response to Streptococcus pneumoniae Infect. Immun., February 1, 2002; 70(2): 749 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Pendl, C. Robert, M. Steinert, R. Thanos, R. Eytner, E. Borges, M. K. Wild, J. B. Lowe, R. C. Fuhlbrigge, T. S. Kupper, et al. Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1 Blood, February 1, 2002; 99(3): 946 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schuler, T. Kammertoens, S. Preiss, P. Debs, N. Noben-Trauth, and T. Blankenstein Generation of Tumor-associated Cytotoxic T Lymphocytes Requires Interleukin 4 from CD8+ T Cells J. Exp. Med., December 17, 2001; 194(12): 1767 - 1775. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kato, Y. Takaue, and H. Wakasugi T-cell-conditioned medium efficiently induces the maturation and function of human dendritic cells J. Leukoc. Biol., December 1, 2001; 70(6): 941 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Kirk, D. Hartigan-O'Connor, and J. J. Mule The Dynamics of the T-Cell Antitumor Response: Chemokine-secreting Dendritic Cells Can Prime Tumor-reactive T Cells Extranodally Cancer Res., December 1, 2001; 61(24): 8794 - 8802. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, B. Schuler-Thurner, G. Schuler, C. Huber, and B. Seliger Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation Int. Immunol., December 1, 2001; 13(12): 1515 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, Y. Okada, T. Fujita, T. Hayakawa, et al. Efficient Antigen Gene Transduction Using Arg-Gly-Asp Fiber-Mutant Adenovirus Vectors Can Potentiate Antitumor Vaccine Efficacy and Maturation of Murine Dendritic Cells Cancer Res., November 1, 2001; 61(21): 7913 - 7919. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kotera, K. Shimizu, and J. J. Mule Comparative Analysis of Necrotic and Apoptotic Tumor Cells As a Source of Antigen(s) in Dendritic Cell-based Immunization Cancer Res., November 1, 2001; 61(22): 8105 - 8109. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mehling, K. Loser, G. Varga, D. Metze, T. A. Luger, T. Schwarz, S. Grabbe, and S. Beissert Overexpression of Cd40 Ligand in Murine Epidermis Results in Chronic Skin Inflammation and Systemic Autoimmunity J. Exp. Med., September 3, 2001; 194(5): 615 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Stober, R. Schirmbeck, and J. Reimann IL-12/IL-18-Dependent IFN-{{gamma}} Release by Murine Dendritic Cells J. Immunol., July 15, 2001; 167(2): 957 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ahlers, I. M. Belyakov, S. Matsui, and J. A. Berzofsky Mechanisms of cytokine synergy essential for vaccine protection against viral challenge Int. Immunol., July 1, 2001; 13(7): 897 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Auffermann-Gretzinger, E. B. Keeffe, and S. Levy Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection Blood, May 15, 2001; 97(10): 3171 - 3176. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, Y. Yu, M. Zhang, W. Wang, and X. Cao The Involvement of TNF-{{alpha}}-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-{{beta}}-Stimulated Human Dendritic Cells to Tumor Cells J. Immunol., May 1, 2001; 166(9): 5407 - 5415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Candido, K. Shimizu, J. C. McLaughlin, R. Kunkel, J. A. Fuller, B. G. Redman, E. K. Thomas, B. J. Nickoloff, and J. J. Mulé Local Administration of Dendritic Cells Inhibits Established Breast Tumor Growth: Implications for Apoptosis-inducing Agents Cancer Res., January 1, 2001; 61(1): 228 - 236. [Abstract] [Full Text] |
||||
![]() |
L. A. Lambert, G. R. Gibson, M. Maloney, B. Durell, R. J. Noelle, and R. J. Barth Jr. Intranodal Immunization with Tumor Lysate-pulsed Dendritic Cells Enhances Protective Antitumor Immunity Cancer Res., January 1, 2001; 61(2): 641 - 646. [Abstract] [Full Text] |
||||
![]() |
C. Brunner, J. Seiderer, A. Schlamp, M. Bidlingmaier, A. Eigler, W. Haimerl, H.-A. Lehr, A. M. Krieg, G. Hartmann, and S. Endres Enhanced Dendritic Cell Maturation by TNF-{alpha} or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo J. Immunol., December 1, 2000; 165(11): 6278 - 6286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koido, M. Kashiwaba, D. Chen, S. Gendler, D. Kufe, and J. Gong Induction of Antitumor Immunity by Vaccination of Dendritic Cells Transfected with MUC1 RNA J. Immunol., November 15, 2000; 165(10): 5713 - 5719. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brasel, T. De Smedt, J. L. Smith, and C. R. Maliszewski Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures Blood, November 1, 2000; 96(9): 3029 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Haddad, J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, S. Kumar, S. L. Hoffman, and W. R. Weiss Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles J. Immunol., October 1, 2000; 165(7): 3772 - 3781. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. E. A. Flesch, D. Stober, R. Schirmbeck, and J. Reimann Monocyte inflammatory protein-1{alpha} facilitates priming of CD8+ T cell responses to exogenous viral antigen Int. Immunol., September 1, 2000; 12(9): 1365 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mehling, S. Grabbe, M. Voskort, T. Schwarz, T. A. Luger, and S. Beissert Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells J. Immunol., September 1, 2000; 165(5): 2374 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bellone, D. Cantarella, P. Castiglioni, M. C. Crosti, A. Ronchetti, M. Moro, M. P. Garancini, G. Casorati, and P. Dellabona Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma J. Immunol., September 1, 2000; 165(5): 2651 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Hodge, A. N. Rad, D. W. Grosenbach, H. Sabzevari, A. G. Yafal, L. Gritz, and J. Schlom Enhanced Activation of T Cells by Dendritic Cells Engineered to Hyperexpress a Triad of Costimulatory Molecules J Natl Cancer Inst, August 2, 2000; 92(15): 1228 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vendetti, J.-G. Chai, J. Dyson, E. Simpson, G. Lombardi, and R. Lechler Anergic T Cells Inhibit the Antigen-Presenting Function of Dendritic Cells J. Immunol., August 1, 2000; 165(3): 1175 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Schuurhuis, S. Laban, R. E.M. Toes, P. Ricciardi-Castagnoli, M. J. Kleijmeer, E. I.H. van der Voort, D. Rea, R. Offringa, H. J. Geuze, C. J.M. Melief, et al. Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell-Independent or-Dependent Stimuli J. Exp. Med., July 3, 2000; 192(1): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Hoffmann, N. Meidenbauer, G. Dworacki, H. Kanaya, and T. L. Whiteside Generation of Tumor-specific T Lymphocytes by Cross-Priming with Human Dendritic Cells Ingesting Apoptotic Tumor Cells Cancer Res., July 1, 2000; 60(13): 3542 - 3549. [Abstract] [Full Text] |
||||
![]() |
T. Kikuchi, M. A. S. Moore, and R. G. Crystal Dendritic cells modified to express CD40 ligand elicit therapeutic immunity against preexisting murine tumors Blood, July 1, 2000; 96(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Klein, H. Bueler, and R. C. Mulligan Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines J. Exp. Med., May 15, 2000; 191(10): 1699 - 1708. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tada, A. Asahina, K. Nakamura, M. Tomura, H. Fujiwara, and K. Tamaki Granulocyte/Macrophage Colony-Stimulating Factor Inhibits IL-12 production of Mouse Langerhans Cells J. Immunol., May 15, 2000; 164(10): 5113 - 5119. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. I. Chapoval, K. Tamada, and L. Chen In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells Blood, April 1, 2000; 95(7): 2346 - 2351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Song, S. W. Lee, Y. S. Suh, K. J. Lee, and Y. C. Sung Enhancement of Immunoglobulin G2a and Cytotoxic T-Lymphocyte Responses by a Booster Immunization with Recombinant Hepatitis C Virus E2 Protein in E2 DNA-Primed Mice J. Virol., March 15, 2000; 74(6): 2920 - 2925. [Abstract] [Full Text] |
||||
![]() |
S. M. Barratt-Boyes, M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano III, M. Murphey-Corb, L. D. Falo Jr., and A. D. Donnenberg Maturation and Trafficking of Monocyte-Derived Dendritic Cells in Monkeys: Implications for Dendritic Cell-Based Vaccines J. Immunol., March 1, 2000; 164(5): 2487 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schnell, J. W. Young, A. N. Houghton, and M. Sadelain Retrovirally Transduced Mouse Dendritic Cells Require CD4+ T Cell Help to Elicit Antitumor Immunity: Implications for the Clinical Use of Dendritic Cells J. Immunol., February 1, 2000; 164(3): 1243 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukao, S. Matsuda, and S. Koyasu Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-{gamma} Production by Dendritic Cells J. Immunol., January 1, 2000; 164(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Corinti, D. Medaglini, A. Cavani, M. Rescigno, G. Pozzi, P. Ricciardi-Castagnoli, and G. Girolomoni Human Dendritic Cells Very Efficiently Present a Heterologous Antigen Expressed on the Surface of Recombinant Gram-Positive Bacteria to CD4+ T Lymphocytes J. Immunol., September 15, 1999; 163(6): 3029 - 3036. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kohrgruber, N. Halanek, M. Groger, D. Winter, K. Rappersberger, M. Schmitt-Egenolf, G. Stingl, and D. Maurer Survival, Maturation, and Function of CD11c- and CD11c+ Peripheral Blood Dendritic Cells Are Differentially Regulated by Cytokines J. Immunol., September 15, 1999; 163(6): 3250 - 3259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Curiel-Lewandrowski, K. Mahnke, M. Labeur, B. Roters, W. Schmidt, R. D. Granstein, T. A. Luger, T. Schwarz, and S. Grabbe Transfection of Immature Murine Bone Marrow-Derived Dendritic Cells with the Granulocyte-Macrophage Colony-Stimulating Factor Gene Potently Enhances Their In Vivo Antigen-Presenting Capacity J. Immunol., July 1, 1999; 163(1): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Melcher, S. Todryk, A. Bateman, H. Chong, N. R Lemoine, and R. G Vile Adoptive Transfer of Immature Dendritic Cells with Autologous or Allogeneic Tumor Cells Generates Systemic Antitumor Immunity Cancer Res., June 1, 1999; 59(12): 2802 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Tillman, T. D. d. Gruijl, S. A. L.-d. Bakker, R. J. Scheper, H. M. Pinedo, T. J. Curiel, W. R. Gerritsen, and D. T. Curiel Maturation of Dendritic Cells Accompanies High-Efficiency Gene Transfer by a CD40-Targeted Adenoviral Vector J. Immunol., June 1, 1999; 162(11): 6378 - 6383. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |